Metagenics Inc. Names Brent Eck As New President And CEO

ALISO VIEJO, Calif., Nov. 2, 2015 /PRNewswire/ -- Metagenics, Inc., a global pioneer in science-based nutrition and wellness, today named Brent Eck as its new President and Chief Executive Officer. Eck is an accomplished leader who joins Metagenics with an entrepreneurial spirit combined with a strong legacy in launching new products and bringing new innovations to market through effective sales and marketing strategies. He spent the last 13 years in global leadership roles at Fresenius Kabi, a global healthcare company that specializes in clinical nutrition. Most recently, he served as executive vice president with responsibility for US sales, marketing, and business development.

"Metagenics is the best kept secret in the healthcare industry," said Eck. As Metagenics' new CEO, Eck's top priorities will be to accelerate the company's growth and promote wellness by driving awareness of Metagenics' continued innovations in leading-edge nutritional solutions. "In my new role as CEO, I intend on working with our executive team and employees to maximize awareness of Metagenics' breakthrough science-based products and empower more individuals to live happier, healthier lives."

Brent was selected with unanimous support from the Metagenics Board of Directors and leadership team following an exhaustive search. "Brent's passion for our business, combined with his global perspective, sales and multi-channel experience makes him an ideal leader to help us deliver on our growth potential and maintain our vision of helping as many people as possible through Metagenics' nutritional solutions," said Roger Colman, Chairman of the Board.

Eck earned his bachelors' degree in mathematics and computer science at Loyola University Chicago.  He will be based at Metagenics' headquarters in Aliso Viejo, CA.

About Metagenics, Inc.
Metagenics, Inc. (www.metagenics.com) is a nutrigenomics company dedicated to helping people live happier, healthier lives by realizing their genetic potential. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle solutions programs such as FirstLine Therapy® to help their patients achieve a lifetime of good health. Metagenics' scientific staffamong the largest in the nutrigenomics industryhas published more than 80 articles in peer-reviewed journals and has been awarded more than 60 patents in the US and around the globe. The company collaborates with renowned medical experts to deliver products and solutions to help healthcare practitioners stay on the leading edge of lifestyle medicine.  Metagenics maintains its corporate headquarters in Aliso Viejo, CA; R&D headquarters in Gig Harbor, WA; and operating subsidiaries in Ostend, Belgium and Brisbane, Australia.

CONTACT: Emily Ryan, Corporate Communications, Telephone: 949.369.3478, Email: [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/metagenics-names-brent-eck-as-new-president-and-ceo-300169613.html

SOURCE Metagenics, Inc.

Suggested Articles

Almirall is pulling the trigger on an option to advance Dermira's lebrikizumab in Europe, a program it reckons could rake in €450 million.

Acer Therapeutics’ stock plummeted more than 78% premarket this morning on news that the FDA had rejected approval of its drug Edsivo (celiprolol).

The latest setback prompted Novartis-partnered Conatus to lay off 40% of its staff and begin looking for strategic alternatives.